CD4 and neoplasm: Indeed, as Maxwell et al. showed in a flank-tumor-bearing mice model, corticosteroid treatment can be responsible for severe and persistent diminution of peripheral CD4+ and CD8+ T cells resulting in lower efficacy for anti-PD-1 treatment [97].